文献速递血管炎

巨细胞动脉炎中血管病变的持续存在:间质细胞是否被忽视?

Vascular disease persistence in giant cell arteritis: are stromal cells neglected?
PubMed 文献 · Ann Rheum Dis · 2024-08-27

本文综述巨细胞动脉炎(GCA)中免疫细胞与间质细胞对血管壁各层的相互作用,指出尽管高剂量糖皮质激素广泛抑制炎症,但超过50%的患者仍复发,血管病变持续存在的机制尚未阐明,其他慢性炎症性疾病提示成纤维细胞及其谱系细胞可能参与疾病慢性化。

要点

  • GCA中炎性细胞因子极化T细胞、激活常驻巨噬细胞并协同增强血管炎症,形成自身反应性环路。
  • 血管病变始于外膜, infiltrating细胞向内膜迁移,功能失调的血管平滑肌细胞和成纤维细胞沿谱系表型转变并定植内膜。
  • 高剂量糖皮质激素广泛抑制炎症但副作用明确,尽管靶向治疗出现,复发仍常见,影响超过50%的患者。

核心结论

  • GCA中血管病变持续存在的机制尚未阐明,其他慢性炎症性疾病研究提示成纤维细胞及其谱系细胞可能通过与免疫细胞相互作用成为疾病慢性化的协调者甚至效应器。

研究设计与样本

  • 本文为叙述性综述,批判性分析免疫细胞和间质细胞对GCA发病机制的贡献及其驱动血管病变持续存在的分子机制。

主要发现

  • GCA易感前提包括衰老和免疫耐受破坏,导致树突状细胞和T细胞功能障碍。
  • 炎症细胞因子极化T细胞、激活常驻巨噬细胞并协同增强血管炎症,形成自身反应性环路;这些事件起源于外膜,并招募细胞浸润并向内膜迁移。
  • GCA血管各层均可见浸润,多种细胞因子和生长因子放大致病过程,激活无效修复机制,功能失调的血管平滑肌细胞和成纤维细胞沿谱系发生表型转变并定植内膜。
  • 高剂量糖皮质激素广泛抑制这些炎症事件但产生众所周知的有害效应;尽管靶向治疗不断涌现,疾病复发仍常见,影响超过50%的患者。
  • GCA患者的颞动脉和主动脉在治疗诱导临床缓解的情况下仍可显示免疫介导的异常。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Giant cell arteritis (GCA), the most common systemic vasculitis, is characterised by aberrant interactions between infiltrating and resident cells of the vessel wall. Ageing and breach of tolerance are prerequisites for GCA development, resulting in dendritic and T-cell dysfunction. Inflammatory cytokines polarise T-cells, activate resident macrophages and synergistically enhance vascular inflammation, providing a loop of autoreactivity. These events originate in the adventitia, commonly regarded as the biological epicentre of the vessel wall, with additional recruitment of cells that infiltrate and migrate towards the intima. Thus, GCA-vessels exhibit infiltrates across the vascular layers, with various cytokines and growth factors amplifying the pathogenic process. These events activate ineffective repair mechanisms, where dysfunctional vascular smooth muscle cells and fibroblasts phenotypically shift along their lineage and colonise the intima. While high-dose glucocorticoids broadly suppress these inflammatory events, they cause well known deleterious effects. Despite the emerging targeted therapeutics, disease relapse remains common, affecting >50% of patients. This may reflect a discrepancy between systemic and local mediators of inflammation. Indeed, temporal arteries and aortas of GCA-patients can show immune-mediated abnormalities, despite the treatment induced clinical remission. The mechanisms of persistence of vascular disease in GCA remain elusive. Studies in other chronic inflammatory diseases point to the fibroblasts (and their lineage cells including myofibroblasts) as possible orchestrators or even effectors of disease chronicity through interactions with immune cells. Here, we critically review the contribution of immune and stromal cells to GCA pathogenesis and analyse the molecular mechanisms by which these would underpin the persistence of vascular disease.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Karabayas M, Ibrahim HE, Roelofs AJ, et al. Vascular disease persistence in giant cell arteritis: are stromal cells neglected? Ann Rheum Dis. 2024. PMID: 38684323. doi:10.1136/ard-2023-225270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。